Overview

Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether injected medications will increase the amount of fat released by a fat cell. We will compare prednisolone (a synthetic cortisone) combined with isoproterenol (a drug given for asthma) versus using isoproterenol alone. We will also test if injections of isoproterenol and prednisolone will shrink the size of lipomas, which are benign fatty tumors.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Pennington Biomedical Research Center
Collaborator:
Lipothera
Treatments:
Adrenergic Agents
Adrenergic Agonists
Cortisone
Isoproterenol
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate